共 10 条
- [1] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.[J]. Connolly, Stuart J.;Ezekowitz, Michael D.;Yusuf, Salim;Eikelboom, John;Oldgren, Jonas;Parekh, Amit;Pogue, Janice;Reilly, Paul A.;Themeles, Ellison;Varrone, Jeanne;Wang, Susan;Alings, Marco;Xavier, Denis;Zhu, Jun;Diaz, Rafael;Lewis, Basil S.;Darius, Harald;Diener, Hans-Christoph;Joyner, Campbell D.;Wallentin, Lars. NEW ENGLAND JOURNAL OF MEDICINE, 2009(12)
- [2] Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X
- [3] Apixaban versus Warfarin in Patients with Atrial Fibrillation[J]. Granger, Christopher B.;Alexander, John H.;McMurray, John J. V.;Lopes, Renato D.;Hylek, Elaine M.;Hanna, Michael;Al-Khalidi, Hussein R.;Ansell, Jack;Atar, Dan;Avezum, Alvaro;Cecilia Bahit, M.;Diaz, Rafael;Easton, J. Donald;Ezekowitz, Justin A.;Flaker, Greg;Garcia, David;Geraldes, Margarida;Gersh, Bernard J.;Golitsyn, Sergey;Goto, Shinya;Hermosillo, Antonio G.;Hohnloser, Stefan H.;Horowitz, John;Mohan, Puneet;Jansky, Petr;Lewis, Basil S.;Luis Lopez-Sendon, Jose;Pais, Prem;Parkhomenko, Alexander;Verheugt, Freek W. A.;Zhu, Jun;Wallentin, Lars. NEW ENGLAND JOURNAL OF MEDICINE, 2011(11)
- [4] Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF[J]. Hankey, Graeme J.;Patel, Manesh R.;Stevens, Susanna R.;Becker, Richard C.;Breithardt, Gunter;Carolei, Antonio;Diener, Hans-Christoph;Donnan, Geoffrey A.;Halperin, Jonathan L.;Mahaffey, Kenneth W.;Mas, Jean-Louis;Massaro, Ayrton;Norrving, Bo;Nessel, Christopher C.;Paolini, John F.;Roine, Risto O.;Singer, Daniel E.;Wong, Lawrence;Califf, Robert M.;Fox, Keith A. A.;Hacke, Werner. LANCET NEUROLOGY, 2012(04)
- [5] Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation[J]. Hart, Robert G.;Pearce, Lesly A.;Halperin, Jonathan L.;Hylek, Elaine M.;Albers, Gregory W.;Anderson, David C.;Connolly, Stuart J.;Friday, Gary H.;Gage, Brian F.;Go, Alan S.;Goldstein, Larry B.;Gronseth, Gary;Lip, Gregory Y. H.;Sherman, David G.;Singer, Daniel E.;van Walraven, Carl. STROKE, 2008(06)
- [6] LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
- [7] Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study[J]. Olesen, Jonas Bjerring;Lip, Gregory Y. H.;Hansen, Morten Lock;Hansen, Peter Riis;Tolstrup, Janne Schurmann;Lindhardsen, Jesper;Selmer, Christian;Ahlehoff, Ole;Olsen, Anne-Marie Schjerning;Gislason, Gunnar Hilmar;Torp-Pedersen, Christian. BMJ-BRITISH MEDICAL JOURNAL, 2011
- [8] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation[J]. Patel, Manesh R.;Mahaffey, Kenneth W.;Garg, Jyotsna;Pan, Guohua;Singer, Daniel E.;Hacke, Werner;Breithardt, Guenter;Halperin, Jonathan L.;Hankey, Graeme J.;Piccini, Jonathan P.;Becker, Richard C.;Nessel, Christopher C.;Paolini, John F.;Berkowitz, Scott D.;Fox, Keith A. A.;Califf, Robert M. NEW ENGLAND JOURNAL OF MEDICINE, 2011(10)
- [9] New approaches to stroke prevention in atrial fibrillation[J]. Testai F.D.;Gorelick P.B. Current Treatment Options in Cardiovascular Medicine, 2010(3)
- [10] Wolf P A, 1983, Neurol Clin, V1, P317